The arrival of Retatrutide ZPHC, at a dosage of 120mg, is creating considerable interest within the weight loss community. This groundbreaking dual GIP and GLP-1 agonist medication appears to offer notable improvements in fat shedding compared to existing therapies. Initial research studies have demonstrated significant reductions in body fat perce